PSMA-Targeted Radioligand Therapy for Androgen Pathway Modulation-Resistant Prostate Cancer (APMR) in the Chemotherapy-Naïve Setting: A Narrative Review and Expert Commentary
This review examines the emerging evidence supporting the use of PSMA-targeted RLT in select patients with chemotherapy-naïve APMR, its potential role within current treatment pathways, and key considerations for patient selection, treatment sequencing, and the involvement of an experienced medical oncologist within a...